Cargando…
A high–throughput digital script for multiplexed immunofluorescent analysis and quantification of sarcolemmal and sarcomeric proteins in muscular dystrophies
The primary molecular endpoint for many Duchenne muscular dystrophy (DMD) clinical trials is the induction, or increase in production, of dystrophin protein in striated muscle. For accurate endpoint analysis, it is essential to have reliable, robust and objective quantification methodologies capable...
Autores principales: | Scaglioni, Dominic, Ellis, Matthew, Catapano, Francesco, Torelli, Silvia, Chambers, Darren, Feng, Lucy, Sewry, Caroline, Morgan, Jennifer, Muntoni, Francesco, Phadke, Rahul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165405/ https://www.ncbi.nlm.nih.gov/pubmed/32303261 http://dx.doi.org/10.1186/s40478-020-00918-5 |
Ejemplares similares
-
A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples
por: Sardone, Valentina, et al.
Publicado: (2018) -
The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy
por: Scaglioni, Dominic, et al.
Publicado: (2021) -
Animal Models for Muscular Dystrophy Show Different Patterns of Sarcolemmal Disruption
por: Straub, Volker, et al.
Publicado: (1997) -
Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy
Publicado: (1996) -
SARCOLEMMAL SCALLOPING AT SHORT SARCOMERE LENGTHS WITH INCIDENTAL OBSERVATIONS ON THE T TUBULES
por: Hagopian, Martin, et al.
Publicado: (1972)